CONMED (CNMD) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

CONMED Revenue Highlights

Latest Revenue (Y)

$1.31B

Latest Revenue (Q)

$337.93M

Main Segment (Y)

General Surgery

Main Geography (Y)

UNITED STATES

CONMED Revenue by Period

CONMED Revenue by Year

Date	Revenue	Change
2024-12-31	$1.31B	5.00%
2023-12-31	$1.24B	19.06%
2022-12-31	$1.05B	3.45%
2021-12-31	$1.01B	17.18%
2020-12-31	$862.46M	-9.70%
2019-12-31	$955.10M	11.11%
2018-12-31	$859.63M	7.94%
2017-12-31	$796.39M	4.31%
2016-12-31	$763.52M	6.17%
2015-12-31	$719.17M	-2.08%
2014-12-31	$734.47M	-2.95%
2013-12-31	$756.75M	-1.35%
2012-12-31	$767.14M	5.80%
2011-12-31	$725.08M	1.59%
2010-12-31	$713.72M	2.73%
2009-12-31	$694.74M	-6.39%
2008-12-31	$742.18M	6.90%
2007-12-31	$694.29M	7.34%
2006-12-31	$646.81M	4.78%
2005-12-31	$617.30M	10.55%
2004-12-31	$558.39M	12.32%
2003-12-31	$497.13M	9.73%
2003-03-31	$453.06M	5.68%
2001-12-31	$428.72M	9.30%
2000-12-31	$392.23M	5.27%
1999-12-31	$372.60M	10.76%
1998-12-31	$336.40M	143.24%
1997-12-31	$138.30M	10.11%
1996-12-31	$125.60M	26.10%
1995-12-31	$99.60M	40.08%
1994-12-30	$71.10M	32.65%
1993-12-31	$53.60M	-

CONMED generated $1.31B in revenue during NA 2024, up 5.00% compared to the previous quarter, and up 136.85% compared to the same period a year ago.

CONMED Revenue by Quarter

Date	Revenue	Change
2025-09-30	$337.93M	-1.29%
2025-06-30	$342.35M	6.56%
2025-03-31	$321.26M	-7.67%
2024-12-31	$347.93M	9.86%
2024-09-30	$316.70M	-4.25%
2024-06-30	$330.75M	6.13%
2024-03-31	$311.63M	-4.71%
2023-12-31	$327.05M	7.38%
2023-09-30	$304.58M	-4.12%
2023-06-30	$317.65M	7.51%
2023-03-31	$295.47M	17.78%
2022-12-31	$250.87M	-8.80%
2022-09-30	$275.09M	-0.76%
2022-06-30	$277.19M	14.39%
2022-03-31	$242.33M	-11.55%
2021-12-31	$273.97M	10.11%
2021-09-30	$248.83M	-2.48%
2021-06-30	$255.16M	9.66%
2021-03-31	$232.68M	-7.97%
2020-12-31	$252.83M	6.30%
2020-09-30	$237.84M	50.73%
2020-06-30	$157.78M	-26.27%
2020-03-31	$214.01M	-19.20%
2019-12-31	$264.87M	13.39%
2019-09-30	$233.59M	-1.96%
2019-06-30	$238.26M	9.11%
2019-03-31	$218.38M	-9.93%
2018-12-31	$242.44M	19.84%
2018-09-30	$202.31M	-4.94%
2018-06-30	$212.82M	5.32%
2018-03-31	$202.06M	-9.21%
2017-12-31	$222.56M	17.06%
2017-09-30	$190.12M	-3.57%
2017-06-30	$197.15M	5.67%
2017-03-31	$186.57M	-8.59%
2016-12-31	$204.09M	10.45%
2016-09-30	$184.79M	-4.47%
2016-06-30	$193.43M	6.75%
2016-03-31	$181.20M	-5.14%
2015-12-31	$191.02M	12.90%
2015-09-30	$169.18M	-6.54%
2015-06-30	$181.03M	1.73%
2015-03-31	$177.94M	-8.03%
2014-12-31	$193.47M	11.43%
2014-09-30	$173.63M	-7.04%
2014-06-30	$186.78M	3.43%
2014-03-31	$180.59M	-10.56%
2013-12-31	$201.91M	13.54%
2013-09-30	$177.83M	-7.18%
2013-06-30	$191.59M	3.32%
2013-03-31	$185.43M	-7.86%
2012-12-31	$201.24M	10.64%
2012-09-30	$181.88M	-4.12%
2012-06-30	$189.69M	-2.38%
2012-03-31	$194.32M	4.71%
2011-12-31	$185.58M	7.39%
2011-09-30	$172.81M	-5.69%
2011-06-30	$183.24M	-0.12%
2011-03-31	$183.45M	-0.34%
2010-12-31	$184.08M	6.90%
2010-09-30	$172.19M	-4.91%
2010-06-30	$181.09M	2.68%
2010-03-31	$176.37M	-7.48%
2009-12-31	$190.63M	8.64%
2009-09-30	$175.47M	6.63%
2009-06-30	$164.57M	0.31%
2009-03-31	$164.06M	-8.47%
2008-12-31	$179.25M	-0.09%
2008-09-30	$179.41M	-6.92%
2008-06-30	$192.75M	1.04%
2008-03-31	$190.77M	0.64%
2007-12-31	$189.57M	-

CONMED generated $337.93M in revenue during Q3 2025, up -1.29% compared to the previous quarter, and up 102.17% compared to the same period a year ago.

CONMED Revenue Breakdown

CONMED Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22
General Surgery	$763.03M	$711.59M	$583.94M
Orthopedic Surgery	$543.99M	$533.16M	$461.53M

CONMED's latest annual revenue breakdown by segment (product or service), as of Dec 24: General Surgery (58.38%), and Orthopedic Surgery (41.62%).

Quarterly Revenue by Product

Product/Service	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19
General Surgery	$199.73M	$201.61M	$182.97M	$384.30M	$186.16M	$192.56M	$190.52M	$179.91M	$176.86M	$164.29M	$156.47M	$157.01M	$134.81M	$143.08M	$147.27M	$125.51M	$135.65M	$97.30M	$114.73M	$123.26M
Orthopedic Surgery	$138.19M	$140.73M	$138.29M	$273.91M	$130.54M	$139.54M	$136.53M	$124.67M	$140.79M	$131.18M	$118.62M	$120.18M	$107.52M	$105.75M	$107.89M	$107.17M	$102.19M	$60.48M	$99.28M	$110.33M

CONMED's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: General Surgery (59.11%), and Orthopedic Surgery (40.89%).

CONMED Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Americas (excluding the United States)	$121.04M	$120.93M	$212.21M	$63.82M	$50.36M
UNITED STATES	$748.22M	$700.16M	$1.16B	$158.55M	$139.72M
EMEA	$243.06M	$226.25M	$395.87M	$108.46M	$91.00M
Asia Pacific	$194.68M	$197.40M	$324.95M	$107.59M	$93.64M

CONMED's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (57.25%), EMEA (18.60%), Asia Pacific (14.90%), and Americas (excluding the United States) (9.26%).

Quarterly Revenue by Country

Country	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
EMEA	$58.68M	$67.78M	$63.68M	$123.85M	$55.52M	$63.69M	$109.11M	$51.44M	$32.58M	$33.12M	$24.69M	$26.91M	$32.06M	$29.98M	$31.13M	$24.16M	$27.12M	$26.05M	$28.27M	$23.10M
Americas (excluding the United States)	$31.44M	$31.88M	$30.11M	$60.59M	$28.82M	$31.64M	$49.99M	$29.33M	$22.62M	$18.99M	$17.42M	$17.77M	$19.99M	$16.17M	$16.61M	$16.12M	$13.71M	$17.38M	$15.20M	$13.77M
UNITED STATES	$193.98M	$190.61M	$183.76M	$379.71M	$183.15M	$185.37M	$428.35M	$170.52M	$52.34M	$48.94M	$49.08M	$45.69M	$40.46M	$37.95M	$42.69M	$37.96M	$40.78M	$37.13M	$42.38M	$38.91M
Asia Pacific	$53.83M	$52.08M	$43.71M	$94.07M	$49.21M	$51.41M	$80.75M	$53.28M	$33.25M	$30.12M	$24.02M	$28.24M	$27.67M	$23.42M	$27.19M	$27.52M	$26.28M	$26.60M	$26.90M	$26.40M

CONMED's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (57.40%), EMEA (17.37%), Asia Pacific (15.93%), and Americas (excluding the United States) (9.30%).

CONMED Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
AHCO	AdaptHealth	$3.26B	$820.31M
CNMD	CONMED	$1.31B	$337.93M
NEOG	Neogen	$894.66M	$209.19M
AZTA	Azenta	$656.32M	$143.94M
NVCR	NovoCure	$605.22M	$167.20M
UFPT	UFP	$504.42M	$154.56M
INMD	InMode	$492.05M	$80.28M
ESTA	Establishment Labs	$166.03M	$53.78M
KMTS	KESTRA MEDICAL	$27.81M	$17.23M
SSII	SS Innovations	$20.65M	$12.83M
NTLA	Intellia Therapeutics	-	$13.78M

CNMD Revenue FAQ

What is CONMED’s yearly revenue?

CONMED's yearly revenue for 2024 was $1.31B, representing an increase of 5.00% compared to 2023. The company's yearly revenue for 2023 was $1.24B, representing an increase of 19.06% compared to 2022. CNMD's yearly revenue for 2022 was $1.05B, representing an increase of 3.45% compared to 2021.

What is CONMED’s quarterly revenue?

CONMED's quarterly revenue for Q3 2025 was $337.93M, a -1.29% decrease from the previous quarter (Q2 2025), and a 6.70% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $342.34M, a 6.56% increase from the previous quarter (Q1 2025), and a 3.51% increase year-over-year (Q2 2024). CNMD's quarterly revenue for Q1 2025 was $321.26M, a -7.67% decrease from the previous quarter (Q4 2024), and a 3.09% increase year-over-year (Q1 2024).

What is CONMED’s revenue growth rate?

CONMED's revenue growth rate for the last 3 years (2022-2024) was 25.02%, and for the last 5 years (2020-2024) was 51.55%.

What are CONMED’s revenue streams?

CONMED's revenue streams in c 24 are General Surgery, and Orthopedic Surgery. General Surgery generated $763.03M in revenue, accounting 58.38% of the company's total revenue, up 7.23% year-over-year. Orthopedic Surgery generated $543.99M in revenue, accounting 41.62% of the company's total revenue, up 2.03% year-over-year.

What is CONMED’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of CONMED was General Surgery. This segment made a revenue of $763.03M, representing 58.38% of the company's total revenue.